| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 02/20/2003 | CA2457814A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
| 02/20/2003 | CA2453506A1 Pramipexole as an anticonvulsant |
| 02/20/2003 | CA2453485A1 Pramipexole for the treatment of adhd |
| 02/19/2003 | EP1284140A2 Use of ritonavir (ABT-538) for improving the pharmacokinetics of drugs metabolized by cytochrome P450 in a method of treating aids |
| 02/19/2003 | EP1283838A1 Piperazine and piperidine compounds |
| 02/19/2003 | EP1283834A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/19/2003 | EP1283833A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/19/2003 | EP1283832A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/19/2003 | EP1283831A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/19/2003 | EP1283830A1 Para-amine substituted phenylamide glucokinase activators |
| 02/19/2003 | EP1283825A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 02/19/2003 | EP1283735A2 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 02/19/2003 | EP1283711A1 Peptide deformylase inhibitors |
| 02/19/2003 | EP0774969B1 Hiv protease inhibitor combination |
| 02/19/2003 | CN1398252A Dehydroamino acids compounds |
| 02/19/2003 | CN1397553A Process for preparing Nizatidine |
| 02/19/2003 | CN1397552A Intermediate for synthetizing thiazolium derivative and its prepn. method |
| 02/19/2003 | CN1101649C Herbicidal synergistic compsn. and method of controlling weeds |
| 02/18/2003 | US6521759 Aminothiazole inhibitors of cyclin dependent kinases |
| 02/18/2003 | US6521754 Benzothiazole derivatives with activity as adenosine receptor ligands |
| 02/18/2003 | US6521666 Inhibitors of α4 mediated cell adhesion |
| 02/18/2003 | US6521652 Thiazoline acid derivatives |
| 02/18/2003 | US6521626 Inhibiting binding of alpha 4 integrins to their ligands; prophylaxis and treatment of immune or inflammatory disorders |
| 02/18/2003 | US6521624 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 02/18/2003 | US6521622 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 02/18/2003 | US6521395 Infrared couplers for incorporating and recovering metadata |
| 02/14/2003 | CA2421046A1 Compositions for enhancing or improving the flavor of foods or drinks and method of enhancing or improving the flavor of foods or drinks by using the same |
| 02/13/2003 | WO2003011843A1 Novel 2,4-diaminothiazole derivatives |
| 02/13/2003 | WO2003011842A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 02/13/2003 | WO2003011819A1 Butyric acid derivatives |
| 02/13/2003 | WO2003011807A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 02/13/2003 | WO2003011290A1 Methods for inhibiting or reversing tau filament formation polymerization |
| 02/13/2003 | WO2002083657A3 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
| 02/13/2003 | WO2002036580A9 Benzoxazole lpaat- beta inhibitors and uses thereof |
| 02/13/2003 | US20030032813 Parathyroid hormone receptor-mediated adenylate cyclase formation; treating osteoporosis |
| 02/13/2003 | US20030032667 Process for preparing amic acid esters |
| 02/13/2003 | US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 02/13/2003 | US20030032635 Heterocyclic esters and amides |
| 02/13/2003 | CA2753329A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 02/13/2003 | CA2455969A1 Methods for inhibiting or reversing tau filament formation polymerization |
| 02/13/2003 | CA2455753A1 Novel 2,4-diaminothiazole derivatives |
| 02/13/2003 | CA2455749A1 Butyric acid derivatives |
| 02/13/2003 | CA2452665A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 02/12/2003 | EP1283205A1 Naphthol derivatives |
| 02/12/2003 | EP1282612A2 Alkynyl phenyl heteroaromatic glucokinase activators |
| 02/12/2003 | EP1282611A1 Substituted phenylacetamides and their use as glucokinase activators |
| 02/12/2003 | EP1282600A1 Inhibitors of dipeptidyl peptidase iv |
| 02/12/2003 | EP1282595A1 Novel phenyl-propargylether derivatives |
| 02/12/2003 | EP1115400A4 Benzothiazole dioxetanes |
| 02/12/2003 | EP0944601B1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 02/12/2003 | CN1397148A Luminescent element material and luminescent element comprising the same |
| 02/12/2003 | CN1396915A Heterocylic derivative, its preparation method and medicine composition containing them |
| 02/12/2003 | CN1396826A Use of pramipexole for treatment of addictive disorders |
| 02/12/2003 | CN1101190C HIV protease inhibitor combination medicine |
| 02/11/2003 | US6518433 Process for the preparation of nitroguanidine derivatives |
| 02/11/2003 | US6518292 Heterocyclic aromatic compounds usefuls as growth hormone secretagogues |
| 02/11/2003 | US6518291 Inosine-5'-monophosphate dehydrogenase inhibitors |
| 02/11/2003 | US6518290 Substituted oxazoles and thiazoles derivatives as HPPAr alpha activators |
| 02/11/2003 | US6518272 HT3 receptor agonists and antagonists; treatment of anxiety, depression, cognitive deficits, and prostate cancer |
| 02/11/2003 | US6518268 Telomerase inhibitors and methods of their use |
| 02/11/2003 | CA2222851C Keratin fibre oxidation dye composition and dye process using the composition |
| 02/10/2003 | WO2002014320A2 Novel substituted diaryl azepine derivatives as integrin ligands |
| 02/10/2003 | CA2419078A1 Substituted diaryl azepine derivatives as integrin ligands |
| 02/06/2003 | WO2003010153A1 N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses |
| 02/06/2003 | WO2003010143A1 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| 02/06/2003 | WO2003009843A1 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 02/06/2003 | WO2003009807A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/06/2003 | WO2002096420A3 Method for treating nerve injury caused by surgery |
| 02/06/2003 | US20030028032 Process for producing substituted alkylamine derivative |
| 02/06/2003 | US20030027845 Ether derivatives useful as inhibitors of PDE4 isozymes |
| 02/06/2003 | US20030027807 Vitronectin receptor antagonists, their preparation and their use |
| 02/06/2003 | US20030027798 For therapy |
| 02/06/2003 | CA2452159A1 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/05/2003 | EP1280797A1 Inhibitors of dipeptidyl peptidase iv |
| 02/05/2003 | EP1280791A1 N-heteroarylmethyl-m-phenylenediamine derivative-containing dyes for keratin fibers and novel n-heteroarylmethyl-m-phenylenediamine derivatives |
| 02/05/2003 | EP1280764A2 Inhibitors of histone deacetylase |
| 02/05/2003 | EP1280757A2 New gamma selective retinoids |
| 02/05/2003 | EP1037868B1 $g(a)-HYDROXY, -AMINO, AND HALO DERIVATIVES OF $g(b)-SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS |
| 02/05/2003 | EP0742201B1 Process for producing aromatic or heteroaromatic sulfur compounds |
| 02/05/2003 | CN1395562A Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 02/05/2003 | CN1395467A Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 02/05/2003 | CN1100748C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substituted phenyl)-4-oxobutyric acids |
| 02/05/2003 | CN1100540C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
| 02/04/2003 | US6515132 Process for the preparation of rosiglitazone maleate |
| 02/04/2003 | US6515124 Dehydroamino acids |
| 02/04/2003 | US6515014 Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| 02/04/2003 | US6515005 Substituted azole derivatives as inhibitors of corticotropin releasing factor |
| 02/04/2003 | US6515003 Useful in the treatment of diseases related to lipid and carbohydrate metabolism |
| 02/04/2003 | US6515001 IL-8 receptor ligands-drugs for inflammatory and autoimmune diseases |
| 02/04/2003 | US6514990 Pharmaceutically active compounds and methods of use |
| 01/30/2003 | WO2003008411A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 01/30/2003 | WO2003008398A1 Aryl substituted thiazolidinones and the use thereof |
| 01/30/2003 | WO2003008370A1 Substituted 4-aminocyclohexanols |
| 01/30/2003 | WO2003008365A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 01/30/2003 | WO2003008362A1 Novel 3-aryl-2-hydroxy propanol derivatives and a process for their preparation |
| 01/30/2003 | WO2003007947A1 Use of 4-[(4-thiazolyl)phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis |
| 01/30/2003 | WO2003007946A1 Secondary 1,3-thiazole-5-yl sulfonamide derivatives and their use as antiviral agents |
| 01/30/2003 | WO2002034243A3 Method for the treatment of neurological and neuropsychological disorders |
| 01/30/2003 | WO2002034242A3 Method for the treatment of neurological and neuropsychological disorders |
| 01/30/2003 | WO2002006267A3 Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin a |